Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Is it time to revise the diagnostic criteria for apathy in brain disorders? The 2018 international consensus group.

Robert P, Lanctôt KL, Agüera-Ortiz L, Aalten P, Bremond F, Defrancesco M, Hanon C, David R, Dubois B, Dujardin K, Husain M, König A, Levy R, Mantua V, Meulien D, Miller D, Moebius HJ, Rasmussen J, Robert G, Ruthirakuhan M, Stella F, Yesavage J, Zeghari R, Manera V.

Eur Psychiatry. 2018 Oct;54:71-76. doi: 10.1016/j.eurpsy.2018.07.008. Epub 2018 Aug 17.

2.

Identification and validation of biomarkers for autism spectrum disorders.

Loth E, Spooren W, Ham LM, Isaac MB, Auriche-Benichou C, Banaschewski T, Baron-Cohen S, Broich K, Bölte S, Bourgeron T, Charman T, Collier D, de Andres-Trelles F, Durston S, Ecker C, Elferink A, Haberkamp M, Hemmings R, Johnson MH, Jones EJ, Khwaja OS, Lenton S, Mason L, Mantua V, Meyer-Lindenberg A, Lombardo MV, O'Dwyer L, Okamoto K, Pandina GJ, Pani L, Persico AM, Simonoff E, Tauscher-Wisniewski S, Llinares-Garcia J, Vamvakas S, Williams S, Buitelaar JK, Murphy DG.

Nat Rev Drug Discov. 2016 Jan;15(1):70-3. doi: 10.1038/nrd.2015.7. No abstract available.

PMID:
26718285
3.

The European Medicines Agency's strategies to meet the challenges of Alzheimer disease.

Haas M, Mantua V, Haberkamp M, Pani L, Isaac M, Butlen-Ducuing F, Vamvakas S, Broich K.

Nat Rev Drug Discov. 2015 Apr;14(4):221-2. doi: 10.1038/nrd4585.

PMID:
25829266
4.

Taking stock: A multistakeholder perspective on improving the delivery of care and the development of treatments for Alzheimer's disease.

Bradley P, Akehurst R, Ballard C, Banerjee S, Blennow K, Bremner J, Broich K, Cummings J, Dening K, Dubois B, Klipper W, Leibman C, Mantua V, Molinuevo JL, Morgan S, Muscolo LA, Nicolas F, Pani L, Robinson L, Siviero P, van Dam J, Van Emelen J, Wimo A, Wortmann M, Goh L.

Alzheimers Dement. 2015 Apr;11(4):455-61. doi: 10.1016/j.jalz.2014.01.007. Epub 2014 Apr 21.

5.

Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014.

Schneider LS, Mangialasche F, Andreasen N, Feldman H, Giacobini E, Jones R, Mantua V, Mecocci P, Pani L, Winblad B, Kivipelto M.

J Intern Med. 2014 Mar;275(3):251-83. doi: 10.1111/joim.12191. Review.

6.

Search for peripheral biomarkers in patients affected by acutely psychotic bipolar disorder: a proteomic approach.

Giusti L, Mantua V, Da Valle Y, Ciregia F, Ventroni T, Orsolini G, Donadio E, Giannaccini G, Mauri M, Cassano GB, Lucacchini A.

Mol Biosyst. 2014 Jun;10(6):1246-54. doi: 10.1039/c4mb00068d. Epub 2014 Feb 19.

PMID:
24554194
7.

Manic episode after ventricular-peritoneal shunt replacement in a patient with radiation-induced hydrocephalus: the role of lifetime subthreshold bipolar features.

Callari A, Mantua V, Miniati M, Benvenuti A, Mauri M, Dell'osso L.

Case Rep Psychiatry. 2014;2014:953728. doi: 10.1155/2014/953728. Epub 2014 Jan 12.

8.

Designing drug trials for Alzheimer's disease: what we have learned from the release of the phase III antibody trials: a report from the EU/US/CTAD Task Force.

Vellas B, Carrillo MC, Sampaio C, Brashear HR, Siemers E, Hampel H, Schneider LS, Weiner M, Doody R, Khachaturian Z, Cedarbaum J, Grundman M, Broich K, Giacobini E, Dubois B, Sperling R, Wilcock GK, Fox N, Scheltens P, Touchon J, Hendrix S, Andrieu S, Aisen P; EU/US/CTAD Task Force Members.

Alzheimers Dement. 2013 Jul;9(4):438-44. doi: 10.1016/j.jalz.2013.03.007.

PMID:
23809364
9.

Bipolar spectrum: just broadening or an integration between categories and dimensions?

Cassano GB, Mantua V, Fagiolini A.

World Psychiatry. 2011 Oct;10(3):192-3. No abstract available.

10.

Does psychomotor retardation define a clinically relevant phenotype of unipolar depression?

Calugi S, Cassano GB, Litta A, Rucci P, Benvenuti A, Miniati M, Lattanzi L, Mantua V, Lombardi V, Fagiolini A, Frank E.

J Affect Disord. 2011 Mar;129(1-3):296-300. doi: 10.1016/j.jad.2010.08.004. Epub 2010 Sep 15.

11.

Microvessel length density, total length, and length per neuron in five subcortical regions in schizophrenia.

Kreczmanski P, Heinsen H, Mantua V, Woltersdorf F, Masson T, Ulfig N, Schmidt-Kastner R, Korr H, Steinbusch HW, Hof PR, Schmitz C.

Acta Neuropathol. 2009 Apr;117(4):409-21. doi: 10.1007/s00401-009-0482-7. Epub 2009 Feb 6.

PMID:
19198859
12.

Volume, neuron density and total neuron number in five subcortical regions in schizophrenia.

Kreczmanski P, Heinsen H, Mantua V, Woltersdorf F, Masson T, Ulfig N, Schmidt-Kastner R, Korr H, Steinbusch HW, Hof PR, Schmitz C.

Brain. 2007 Mar;130(Pt 3):678-92. Epub 2007 Feb 15.

PMID:
17303593

Supplemental Content

Loading ...
Support Center